跳至主要内容
临床试验/NCT04761276
NCT04761276Unknown不适用

Evaluation of Efficacy and Long-term Safety for Lucidis Instant Focus© - PMCF Study Protocol

SAV-IOL SA1 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2021年5月21日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
120
试验地点
1
主要终点
Visual acuity measure BCVA photopic

研究概览

简要总结

The objectives of the study is to evaluate efficacy and long-term safety of the Lucidis lens. Through this study, the objective is to obtain an up-to-date clinical evaluation of the medical device thus supplementing data from experimental trials. Clinical and functional changes in the implanted eyes among a patient population in which the opaque crystalline lens resulting from cataract was removed and replaced by a Lucidis IOL will be described.

详细描述

Refractory function in patients with a cataract is mainly restored by implanting intra-ocular lenses (IOL) destined to replace the crystalline lens. While new surgical techniques for removing the crystalline lens have been developed, these lenses have been considerably perfected to resemble the natural crystalline lens as closely as possible.

The objectives of the study is to evaluate efficacy and long-term safety of the Lucidis lens. Through this study, the objective is to obtain an up-to-date clinical evaluation of the medical device thus supplementing data from experimental trials. Clinical and functional changes in the implanted eyes among a patient population in which the opaque crystalline lens resulting from cataract was removed and replaced by a Lucidis IOL will be described.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • adult patients (≥18 years)
  • having agreed to take part in the study and complete post-operative follow-up requirements (by having signed the information leaflet-informed consent form);
  • for whom the physician made the decision to implant a Lucidis

排除标准

  • patient included in an interventional therapeutic trial at the time of inclusion;
  • patient presenting contraindications for the implantation of an intraocular lens;
  • patient presenting an ophthalmic disorder liable to interfere with the study endpoints;
  • patient presenting with an astigmatism ≥1.0 D;
  • patient refusing or unable to comply with the follow-up procedures in the study (patient unable to be reached by telephone, liable to be lost to follow-up, etc.);
  • History of previous intraocular surgery in the study eye in the previous 6 months;
  • patient is pregnant, breast-feeding or unable to make the decision to participate in a clinical investigation (e.g. mentally ill or handicapped person)

结局指标

主要结局

Visual acuity measure BCVA photopic

时间窗: 1 year

Far Best Corrected Visual Acuity in photopic conditions

Visual acuity measure UCVA mesopic

时间窗: 1 year

Near, intermediate and far Uncorrected visual acuity in mesopic conditions

Visual acuity measure BCVA mesopic

时间窗: 1 year

Far Best Corrected Visual Acuity in mesopic conditions

Visual acuity measure UCVA photopic

时间窗: 1 year

Near, intermediate and far Uncorrected visual acuity in photopic conditions

次要结局

  • Safety assessment(1 year)
  • Contrast sensitivity measure mesopic(1 year)
  • Contrast sensitivity measure photopic(1 year)

研究者

发起方
SAV-IOL SA
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Evaluation of Efficacy and Long-term Safety for... | 临床试验